← Medical · Causes of death · how systems treat it
Cancer · Master rank #14 · ~1.9% of deaths (Top 20 avg)
Short comparison of all 20 systems on one page. Click a country for the full treatment / prevention / lifestyle page.
Strong primary care gatekeeping with private hospital overflow. Cancer pathway via Universal Medicare + private optional.
Insurer-organized pathways; low uninsured rate. Cancer pathway via Mandatory private insurance, regulated.
GP gatekeeping, NICE pathways, waiting-list rationing for elective care. Cancer pathway via NHS tax-funded.
Pharmac constrains drug spend; public hospitals for major care. Cancer pathway via Tax-funded + private optional.
High spend, high access, canton variation. Cancer pathway via Mandatory private insurance.
Municipal prevention + regional hospitals. Cancer pathway via Tax-funded.
Single-payer core with wait times; limited private parallel. Cancer pathway via Single payer (provincial).
Strong primary care; Mediterranean public-health framing. Cancer pathway via SNS tax-funded.
Ambulatory specialists + hospital sector; dense capacity. Cancer pathway via Statutory sickness funds.
Fund-integrated care; strong tech/trauma capacity. Cancer pathway via Mandatory health funds.
GP gatekeeping; north/south performance gaps. Cancer pathway via SSN tax-funded.
Primary-care centered; strong public health infrastructure. Cancer pathway via Decentralized tax-funded.
Wealthy Nordic model; GP lists + municipal prevention. Cancer pathway via Tax-funded national system.
Ambulatory specialist access; strong pharma/device availability. Cancer pathway via Statutory health insurance.
Public primary care + occupational health overlay. Cancer pathway via Tax-funded / reforming.
Public clusters for most serious care; private ISP for those who pay up. Cancer pathway via S+3Ms (subsidy + MediSave + MediShield + MediFund).
High ambulatory volume; global budgets constrain growth. Cancer pathway via NHI single payer.
High-tech acute care; prior auth; huge price variation by payer. Cancer pathway via Medicare/Medicaid + commercial.
High visit frequency, low unit prices, specialist access without US-style referral walls. Cancer pathway via Statutory insurance, fee schedule.
Very high utilization; hospital-heavy; aggressive screening culture. Cancer pathway via NHI single payer + private hospitals.